Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Phadia AB plans to provide access for specialists to peanut allergen components

Today, at the 2010 Annual Meeting of The American Academy of Allergy, Asthma & Immunology (AAAAI) Phadia, the world leader in in vitro allergy diagnostics, announced plans to provide access for specialists to peanut allergen components. These plans support Phadia’s goal to expand collaboration with allergy and immunology specialists in order to advance the understanding of the clinical utility of allergen component test results.

27 Feb 2010

CPIPA selects ICA’s CareAlign technology to broaden existing reporting functions

Informatics Corporation of America (ICA), unmatched in its ability to deliver a cost-effective, proven solution that leverages complete data across clinical settings to aid decision-making and improve patient outcomes, announced that its CareAlign™ technology was selected by Tennessee-based Cumberland Pediatrics Independent Practice Association (CPIPA).

27 Feb 2010

Approval of smoke-free legislation: Huge step forward to protect workers and public from secondhand smoke

The Kansas Legislature today delivered a historic victory for health and the public's right to breathe clean air by passing legislation to make almost all workplaces, including all restaurants and bars, smoke-free.

26 Feb 2010

SynCare receives NCQA Accreditation for high-risk pregnancy program

SynCare, LLC has received National Committee for Quality Assurance Patient and Practitioner Oriented Full Accreditation for its high-risk pregnancy program, the SynCare Promise Program™ for Prenatal Care.

26 Feb 2010

Inverseon comments on LABAs and INV102CR drugs

Inverseon, Inc. (http://www.inverseon.com) comments on Long Acting Beta-Agonists (LABAs) and INV102CR.

25 Feb 2010

Study examines range of health issues and trends among older women in California

Older women who are divorced, separated or widowed or who have never married have twice the uninsured rate of their married peers, according to a new policy brief from the UCLA Center for Health Policy Research.

25 Feb 2010

FDA's warning over LABA medications for asthma: AANMA offers guidance

Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).

24 Feb 2010

Hudson Health Plan deploys Health Integrated Synergy Targeted Population Management program

Hudson Health Plan, a not-for-profit managed care organization that services New York's Hudson Valley, has selected Health Integrated, Inc., a leading provider of Health Management Solutions, as its partner to provide enhanced care management services for Medicaid members with co-morbid chronic illness.

24 Feb 2010

GW report: Asthma is on the rise in America and more than 1M children with asthma not insured

Researchers from The George Washington University, School of Public Health and Health Services said today that asthma, a largely manageable and chronic disease, is on the rise in America and released new data on the magnitude of the asthma crisis, the surging cost of treatment, and the more than 1 million children with asthma who are uninsured.

24 Feb 2010

Researchers receive grant to study how ILD appears in patients with autoimmune diseases

Researchers at the University of Cincinnati Interstitial Lung Disease Center have received a grant from the National Heart, Lung and Blood Institute to study ways ILD first appears in certain patient groups with autoimmune diseases and how to more efficiently diagnose and treat it.

24 Feb 2010

Cephalon to acquire Ception Therapeutics following positive clinical study of eosinophilic asthma

Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma.

23 Feb 2010

FDA issues approval for Gileads's Cayston for respiratory symptoms in cystic fibrosis

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston’s safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.

23 Feb 2010

The Children's House agrees to provide services for children with asthma

The Justice Department today announced a settlement agreement with The Children's House Inc. of Broadview Heights, Ohio, a suburb of Cleveland, to provide services for children with asthma as required by the Americans with Disabilities Act (ADA).

22 Feb 2010

Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has evaluated the content of the Company's Complete Response submission for Prolia™ (denosumab) in the treatment of postmenopausal osteoporosis and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act (PDUFA) action date of July 25, 2010.

20 Feb 2010

NBCH's annual report: How America's health plans are doing to improve care and control costs for diabetes

Today the National Business Coalition on Health issued its annual report on how America's health plans are doing to improve care and control costs for diabetes. The analysis is based on health plan survey data from NBCH's eValue8™ program, the nation's leading Request for Information (RFI) tool used by employers, coalitions and their purchaser members to set expectations and measure health plan performance.

19 Feb 2010

FDA's proposed label changes for LABA asthma medications: GSK reviews

GlaxoSmithKline is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK's Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted.

19 Feb 2010

Asthma: LABAs should not be used alone

The U.S. Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma in children or adults. Manufacturers will be required to include this warning in the product labels of these drugs, along with taking other steps to reduce the overall use of these medications.

19 Feb 2010

Latino parents with asthmatic child more likely to quit smoking: Study

Asthma is the most common chronic illness affecting Latino children in the United States, and secondhand smoke is a serious contributing factor. Now a new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine and Brown University suggests that clinically-based smoking cessation programs may not be enough to help Latino smokers with asthmatic children kick the habit.

18 Feb 2010

Healthy immune response depends on TRPV2 protein

If bad bacteria lurk in your system, chances are they will bump into the immune system's protective cells whose job is gobbling germs.

18 Feb 2010

AAFA launches national PSA on "Two Main Causes of Asthma"

The Asthma and Allergy Foundation of America (AAFA) is launching a national public service announcement (PSA) supported by GlaxoSmithKline titled "Two Main Causes of Asthma." The PSA goal is to communicate an important message to the millions of Americans with asthma: that treating the two main causes of asthma symptoms may help prevent symptoms before they begin. Asthma symptoms include coughing, wheezing, difficulty breathing and chest tightness.

17 Feb 2010

Asthma News and Research

Further Reading

Phadia AB plans to provide access for specialists to peanut allergen components

CPIPA selects ICA’s CareAlign technology to broaden existing reporting functions

Approval of smoke-free legislation: Huge step forward to protect workers and public from secondhand smoke

SynCare receives NCQA Accreditation for high-risk pregnancy program

Inverseon comments on LABAs and INV102CR drugs

Study examines range of health issues and trends among older women in California

FDA's warning over LABA medications for asthma: AANMA offers guidance

Hudson Health Plan deploys Health Integrated Synergy Targeted Population Management program

GW report: Asthma is on the rise in America and more than 1M children with asthma not insured

Researchers receive grant to study how ILD appears in patients with autoimmune diseases

Cephalon to acquire Ception Therapeutics following positive clinical study of eosinophilic asthma

FDA issues approval for Gileads's Cayston for respiratory symptoms in cystic fibrosis

The Children's House agrees to provide services for children with asthma

Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date

NBCH's annual report: How America's health plans are doing to improve care and control costs for diabetes

FDA's proposed label changes for LABA asthma medications: GSK reviews

Asthma: LABAs should not be used alone

Latino parents with asthmatic child more likely to quit smoking: Study

Healthy immune response depends on TRPV2 protein

AAFA launches national PSA on "Two Main Causes of Asthma"

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News